Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

biOasis Technologies Ord Shs BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


GREY:BIOAF - Post by User

Post by narmacon Jan 17, 2023 2:07pm
161 Views
Post# 35228646

Midatech Bull board / chat room!

Midatech Bull board / chat room!This off the London East chat room for Midatech!

1)So the new investors who took 75% of the company are in at 5.85 p so there should hopefully be at least a return to that. I have taken some at just under 3p
It may have been more kind to shareholders to put this company to sleep as the is there worst fundraise yet.

To say there is no time to raise funds if this proposal is rejected is merely statement that they did not act earlier , and probably by design as old stamp was shooting his mouth off a year ago about a merger.

2)
thought that
bottom was when Armistice closed their short. added some after short closed. was wrong
second bottom was when Armistice bought @3.29 & was wrong again.
have not added/sold yet since news
Lombard still holding some with higher average & no action from CMS + A&B (HK) so far.
Holding a stick with both ends manured

3)
Now I’ve just noticed IN RNS, on holder who has sold last week. Poor guy must be desperately sad, but I guess has a chance to average down here.. The Board is aware that one party which has provided a Letter of Intent has reduced its shareholding in the Company, impacting the number of shares subject to Letters of Intent. The Board will provide an update on shareholder intentions so far as it is able in the Circular to be posted in January 2023.

4)
looks at least 15% holding off

"As of the date hereof, we have been notified by a shareholder purporting to represent shareholders holding over 15% of our outstanding shares that they may not support and approve the transactions contemplated by the Arrangement Agreement."

or
)One might hope so, but having owned BTI (BIOAF) for over 7 years: we have seen a few changes of management and were always told the new ones will get deal done; xB3 had to be reformulated because the original version was too expensive to manufacture; various agreements with well-known companies have been announced, but just petered-out with no actual official explanation and very little in the way of actual results.

The lack of any explanation as to what has happened to all these prospective deals has been particularly frustrating, and now it is difficult to believe xB3 really does work as expected.

Or there is the new conspiracy theory that this is all a ruse to take xB3 private (the new financiers will have over 50% so can do it without our approval), ie it does work.

6)
... this is approved - Stamp is trying to promote this as a win, and it is - for him and and new shareholders. I will take years for the SP to recover to any reasonable level and AIM traders will now have to transfer to US ADR's in the process. Stamp needs to get an interview set up to explain to the markets why he is so happy. The rest of us are not

7)
<< Previous
Bullboard Posts
Next >>